NewsScientific Community

Courts Take a Narrow View of UC's Claims

+ See all authors and affiliations

Science  22 Aug 1997:
Vol. 277, Issue 5329, pp. 1029
DOI: 10.1126/science.277.5329.1029

You are currently viewing the summary.

View Full Text

Summary

A 7-year patent dispute between the University of California and Eli Lilly and Company over rights to the insulin gene could prove troublesome for companies and researchers making broad claims on genes. The courts have ruled that a patent based on a landmark discovery of the rat insulin gene in 1977 does not cover the production of human insulin.

Related Content